ArticleIndian journal of psychiatry2025
Quality of life and financial implications of depression in India.
Article in Indian journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Is universal depression screening cost-effective across all Indian states? Addressing parameter uncertainty: author's reply.The Lancet regional health. Southeast Asia · 2026Article
- Comprehensive primary health care for cost-effective scale-up of depression screening in India: an economic modelling study.The Lancet regional health. Southeast Asia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression is a major public health problem in India, placing a substantial burden on individuals, families, and society. Besides clinical assessment, quality of life (QoL) and out-of-pocket expenditure (OOPE) are key measures to assess the impact of this condition on a patient's wellbeing. However, there is a dearth of published evidence on both these outcomes from India. Moreover, there is no evidence of concordance between common tools for measuring QoL in patients with depression in Indian settings. Aim: This study aims to assess QoL using the EQ-5D-5L and WHOQOL-BREF tools, estimate OOPE for depression care, identify factors associated with QoL and OOPE, and explore the correlation between the QoL derived from both tools. Methods: A cross-sectional survey was conducted at a public tertiary care facility in India, involving semistructured interviews with 259 depression patients. Mean QoL and OOPE were estimated. Multiple linear regression was employed to identify factors associated with QoL and OOPE, while Pearson's correlation coefficient was used to assess the relationship between EQ-5D-5L and WHOQOL-BREF domain scores. Results: The mean EQ-5D-5L utility score was 0.731, while the QoL derived from WHOQOL-BREF ranged from 50.41 to 61.00, across the four domains. Factors like depression severity, perceived support, physical activity, and literacy were significantly associated with QoL. The annual OOPE for depression treatment was ₹35,101. Moderate to strong correlations were observed between EQ-5D-5L and WHOQOL-BREF "physical health" (r = 0.605) and "psychological" (r = 0.553) domains, with weaker correlations for "social relationships" (r = 0.255) and "environment" (r = 0.292). Conclusion: Depression leads to significant financial burden on the patient and the family and is associated with lower QoL. Future research should explore the addition of relevant bolt-on dimensions to the EQ-5D-5L to improve its sensitivity in depression assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.